GRIA2

From WikiMD's WELLNESSPEDIA

GRIA2 is a gene that encodes the GluR2 subunit of the AMPA receptor, a type of ionotropic glutamate receptor in the human body. The AMPA receptor is a non-NMDA-type ionotropic transmembrane receptor for glutamate that mediates fast synaptic transmission in the central nervous system (CNS). Its name is derived from its ability to be activated by the artificial glutamate analog AMPA.

Structure[edit]

The GRIA2 gene is located on the long (q) arm of chromosome 4 at position 32.1. The encoded protein, GluR2, is 883 amino acids long, with a molecular weight of approximately 99 kDa. The protein is composed of an extracellular N-terminus, a transmembrane domain, and an intracellular C-terminus.

Function[edit]

The GluR2 subunit, encoded by the GRIA2 gene, is critical for controlling the calcium permeability of AMPA receptors. When present, GluR2 makes the AMPA receptor impermeable to calcium ions (Ca2+), which is crucial for normal brain function and preventing excitotoxicity.

Clinical significance[edit]

Mutations in the GRIA2 gene have been associated with a variety of neurological and psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder, and autism spectrum disorder.

Research[edit]

Research into the GRIA2 gene and its encoded protein, GluR2, continues to be a significant focus in neuroscience, particularly in understanding the molecular mechanisms underlying synaptic plasticity and neurological disorders.


{{Navbox | name = Genes on human chromosome 4 | title = Genes on human chromosome 4 | listclass = hlist

| group1 = Locus 4p16.3 | list1 =

| group2 = Locus 4q21-q22 | list2 =

| group3 = Locus 4q25 | list3 =

| group4 = Locus 4q28.3 | list4 =

| group5 = Locus 4q31.21 | list5 =

| group6 = Locus 4q32-q35 | list6 =

| group7 = Other notable genes | list7 =



Ionotropic glutamate receptors
Receptor Subtypes
AMPA Receptor Subunits
Kainate Receptor Subunits
NMDA Receptor Subunits
Related Articles
This Ionotropic glutamate receptors related article is a stub.


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=GRIA2&oldid=6507650"